Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CADD522 (MFCD00167693) is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA binding with an IC50 of 10 nM, with antitumor activity
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 61.00 | |
25 mg | In stock | $ 133.00 | |
50 mg | In stock | $ 226.00 | |
100 mg | In stock | $ 397.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | CADD522 (MFCD00167693) is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA binding with an IC50 of 10 nM, with antitumor activity |
In vitro | CADD522 is a potent inhibitor of runt-related transcription factor-2 (RUNX2)-DNA binding( IC50 of 10 nM), has antitumor activity |
Synonyms | MFCD00167693 |
Molecular Weight | 326.17 |
Formula | C15H13Cl2NO3 |
CAS No. | 199735-88-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL(751.14 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CADD522 199735-88-1 Others inhibit CADD 522 MDA-231 Inhibitor Reactive Oxygen Species MCF7 MDA-468 MFCD00167693 breast cancer MFCD-00167693 MFCD 00167693 CADD-522 T47D-RUNX2 inhibitor